Description
Molecular Characteristics:
- Molecular Weight: 4117.8 Daltons
- Formulation: Water-soluble protein
Indications: Teriparatide is indicated for the treatment of:
- Postmenopausal Osteoporosis: Significantly decreases the risk of vertebral and non-vertebral fractures when administered at a daily dose of 20 mcg.
- Men with Osteoporosis: Designed for men with primary or hypogonadal osteoporosis at high risk for fractures, particularly those who have failed or are intolerant to other available osteoporosis therapies.
- Glucocorticoid-Induced Osteoporosis: For men and women experiencing osteoporosis associated with sustained systemic glucocorticoid therapy who are at high risk for fracture.
Benefits:
- Fracture Risk Reduction: Daily administration effectively reduces the incidence of vertebral and non-vertebral fractures in high-risk populations.
- Bone Mass Increase: Promotes increased bone mass and density, enhancing overall skeletal strength.
Dosage and Administration:
- Dosage: 20 mcg once daily via subcutaneous injection.
- Administration Route: Subcutaneous injection in the thigh or abdomen.
Storage:
- Store in the refrigerator (2°C to 8°C). Do not freeze. Protect from light.
Quality Assurance: Manufactured in FDA-approved facilities following WHO GMP guidelines to ensure the highest standards of quality and safety.
Reviews
There are no reviews yet.